Maria P Sormani
Overview
Explore the profile of Maria P Sormani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
1212
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Coerver E, Kacar S, Ciccarelli O, Sormani M, Barkhof F, Arnold D, et al.
Mult Scler
. 2024 Sep;
30(10):1296-1308.
PMID: 39245991
Background: Higher age is associated with less inflammatory disease activity in relapsing-remitting multiple sclerosis (RRMS). It is unknown whether age itself or disease duration underlies this association. Objectives: This study...
2.
Cremante M, Pastorino A, Ponzano M, Grassi M, Martelli V, Puccini A, et al.
Eur J Cancer
. 2023 Feb;
182:115-121.
PMID: 36758476
Background: Patient-reported outcomes (PROs) are validated tools to assess the impact of efficacy and toxicities of cancer treatments on patients' health status. Because of the demonstrated little reliability of humans...
3.
Nicholas R, Rhone E, Mariottini A, Silber E, Malik O, Singh-Curry V, et al.
Neurology
. 2021 Jul;
97(9):e890-e901.
PMID: 34253634
Objective: To examine outcomes in people with multiple sclerosis (PwMS) treated with autologous hematopoietic stem cell transplantation (AHSCT) in a real-world setting. Methods: This was a retrospective cohort study of...
4.
Sormani M, De Rossi N, Schiavetti I, Carmisciano L, Cordioli C, Moiola L, et al.
Ann Neurol
. 2021 Jan;
89(4):780-789.
PMID: 33480077
Objective: This study was undertaken to assess the impact of immunosuppressive and immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID-19) in people with multiple sclerosis (PwMS). Methods: We...
5.
Lebrun-Frenay C, Kantarci O, Siva A, Sormani M, Pelletier D, Okuda D
Ann Neurol
. 2020 Jun;
88(2):407-417.
PMID: 32500558
Objective: We have previously identified male sex, younger age, and the presence of spinal cord lesions as independent factors that increase the 5-year risk for evolution from radiologically isolated syndrome...
6.
Sastre-Garriga J, Pareto D, Battaglini M, Rocca M, Ciccarelli O, Enzinger C, et al.
Nat Rev Neurol
. 2020 Feb;
16(3):171-182.
PMID: 32094485
Early evaluation of treatment response and prediction of disease evolution are key issues in the management of people with multiple sclerosis (MS). In the past 20 years, MRI has become...
7.
Tur C, Kalincik T, Oh J, Sormani M, Tintore M, Butzkueven H, et al.
Neurology
. 2019 Oct;
93(18):793-809.
PMID: 31591277
Disease-modifying drugs are changing the natural history of multiple sclerosis (MS). However, currently available clinical trial data are insufficient to develop accurate personalized treatment algorithms to assign the best possible...
8.
Casaccia M, Sormani M, Palombo D, Dellepiane C, Ibatici A
Surg Laparosc Endosc Percutan Tech
. 2019 Feb;
29(3):178-181.
PMID: 30720696
The objective of this study was to derive some useful parameters to define the feasibility of laparoscopic splenectomy (LS) in massive [spleen longitudinal diameter (SLD)>20 cm] and giant spleens (SLD>25 ...
9.
Benedetti L, Briani C, Beronio A, Massa F, Giorli E, Sani C, et al.
J Peripher Nerv Syst
. 2018 Nov;
24(1):80-86.
PMID: 30421471
Guillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy with a worldwide incidence of 0.81-1.89 per 100 000 person-years. In Europe and North America only 5% of patients with GBS have...
10.
Alberti M, Mori L, Francini L, Poggi I, Bragadin M, Bellone E, et al.
J Peripher Nerv Syst
. 2015 Oct;
20(4):410-4.
PMID: 26456943
To describe a new test to quantitatively evaluate hand function in patients affected by Charcot-Marie-Tooth neuropathy (CMT). The sensor-engineered glove test (SEGT) was applied to CMT patients (N: 26) and...